Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
22M
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
6.59M
-
Shares change
-
-275K
-
Total reported value, excl. options
-
$13.1M
-
Value change
-
-$546K
-
Put/Call ratio
-
2
-
Number of buys
-
8
-
Number of sells
-
-13
-
Price
-
$1.99
Significant Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q4 2023
34 filings reported holding XGN - EXAGEN INC. - Common Stock, par value $0.001 per share as of Q4 2023.
EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.59M shares
of 22M outstanding shares and own 29.92% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (1.5M shares), COWEN AND COMPANY, LLC (899K shares), WASATCH ADVISORS LP (850K shares), Stonepine Capital Management, LLC (670K shares), SILVERCREST ASSET MANAGEMENT GROUP LLC (545K shares), PERKINS CAPITAL MANAGEMENT INC (509K shares), VANGUARD GROUP INC (491K shares), MORGAN STANLEY (484K shares), Nantahala Capital Management, LLC (97.1K shares), and GEODE CAPITAL MANAGEMENT, LLC (81.6K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.